- Home
- KIO vs CYRX Comparison
KIO vs CYRX Comparison
Compare KIO & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KIO | CYRX |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.1M | 421.6M |
| IPO Year | 2011 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KIO | CYRX |
|---|---|---|
| Price | $10.94 | $8.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 347.8K | ★ 385.5K |
| Earning Date | 01-01-0001 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $9.71 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | ★ N/A | $5.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.69 | $4.63 |
| 52 Week High | $12.83 | $11.45 |
Technical Indicators
Market Signals| Indicator | KIO | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.82 | 44.57 |
| Support Level | N/A | $8.07 |
| Resistance Level | $12.51 | $8.45 |
| Average True Range (ATR) | 0.16 | 0.47 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 27.97 | 29.71 |
Price Performance
Historical ComparisonAbout KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.